English

EYETECH PHARMACEUTICALS INC

EDGAR

Current report (8-K) · filed 2005-11-10

10 filing records in this dataset, filed from 2004-03-24 to 2005-11-10. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

57.1 million USD

2005-06-30 · USD

Exact inputs and evidence

Revenue: 57134000 USD Source

Operating margin

-15.58%

2005-06-30 · %

Exact inputs and evidence

Operating Income: -8902000 USD Source
Revenue: 57134000 USD Source

Operating cash flow

-120 thousand USD

2005-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: 42743000 USD Source
Operating Cash Flow: 42863000 USD Source

Free cash flow

-2.41 million USD

2005-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: 42743000 USD Source
Operating Cash Flow: 42863000 USD Source
Capital Expenditure: 6584000 USD Source
Capital Expenditure: 4297000 USD Source

Cash and cash equivalents: 74.4 million USD 2005-06-30 Source
Exact value

74376000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-76.9 million USD

2004-07-01 – 2005-06-30

Exact inputs and evidence

Net income: -24716974 USD · 2004-07-01 – 2004-09-30 Source
Net income: -100505807 USD · 2004-01-01 – 2004-12-31 Source
Net income: -70750418 USD · 2004-01-01 – 2004-09-30 Source
Net income: -15389000 USD · 2005-01-01 – 2005-03-31 Source
Net income: -7068000 USD · 2005-04-01 – 2005-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2005-11-10.

Financial data available through: 2004-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 4 of 11 periods available· newest 2004-12-31
Net income: 4 of 11 periods available· newest 2004-12-31
Operating cash flow: 4 of 11 periods available· newest 2004-12-31
Capital expenditure: 4 of 11 periods available· newest 2004-12-31
Total assets: 3 of 11 periods available· newest 2004-12-31
liabilities: No compatible figures in this window
Current assets: 3 of 11 periods available· newest 2004-12-31
Current liabilities: 3 of 11 periods available· newest 2004-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2004-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 59.81 million

Prior period

−USD 40.7 million

2003-01-01 – 2003-12-31
Current period

−USD 100.51 million

2004-01-01 – 2004-12-31

Exact inputs and evidence

-100505807 − -40699245 = -59806562 USD

-40699245 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
-100505807 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · EYETECH PHARMACEUTICALS INC · 2004-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Year-over-year change in Net income: -59806562 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -100505807 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#19895 Input fundies:NetIncome: -40699245 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#19895
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-268.6%

Prior period

USD 39.44 million

2003-01-01 – 2003-12-31
Current period

−USD 66.51 million

2004-01-01 – 2004-12-31

Exact inputs and evidence

-66514060 − 39440745 = -105954805 USD

39440745 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
-66514060 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · EYETECH PHARMACEUTICALS INC · 2004-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Year-over-year change in Operating cash flow: -105954805 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -66514060 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#20194 Input fundies:OperatingCashFlow: 39440745 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#20194
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+231.7%

Prior period

USD 3.78 million

2003-01-01 – 2003-12-31
Current period

USD 12.53 million

2004-01-01 – 2004-12-31

Exact inputs and evidence

12532316 − 3778026 = 8754290 USD

3778026 USD · 2003-01-01 – 2003-12-31
Inspect prior input Prior source
12532316 USD · 2004-01-01 – 2004-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · EYETECH PHARMACEUTICALS INC · 2004-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Year-over-year change in Capital expenditure: 8754290 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 12532316 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#20232 Input fundies:CapitalExpenditure: 3778026 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#20232
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2001 2001-01-01 – 2001-12-31	−USD 24.68 million Exact value Exact value: -24679930 USD 2001-01-01 – 2001-12-31: -24679930 USD Inspect Net Income Open source Share or cite Citation for Net Income · EYETECH PHARMACEUTICALS INC · 2001-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Net Income: -24679930 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24679930 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-04-003723.txt#18129 The citation records this snapshot. The page link may show a newer release later.	−USD 19.27 million Exact value Exact value: -19268776 USD 2001-01-01 – 2001-12-31: -19268776 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EYETECH PHARMACEUTICALS INC · 2001-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Operating Cash Flow: -19268776 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19268776 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-04-003723.txt#18445 The citation records this snapshot. The page link may show a newer release later.	USD 192,840 Exact value Exact value: 192840 USD 2001-01-01 – 2001-12-31: 192840 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EYETECH PHARMACEUTICALS INC · 2001-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Capital Expenditure: 192840 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 192840 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-04-003723.txt#18485 The citation records this snapshot. The page link may show a newer release later.	−USD 19.46 million Calculation and evidence -19268776 − 192840 USD Exact free cash flow: -19461616 USD 2001-01-01 – 2001-12-31: -19268776 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 192840 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EYETECH PHARMACEUTICALS INC · 2001-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Free cash flow: -19461616 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19268776 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-04-003723.txt#18445 Input fundies:CapitalExpenditure: 192840 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-04-003723.txt#18485 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 43.17 million Exact value Exact value: -43173462 USD 2002-01-01 – 2002-12-31: -43173462 USD Inspect Net Income Open source Share or cite Citation for Net Income · EYETECH PHARMACEUTICALS INC · 2002-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Net Income: -43173462 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -43173462 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#19895 The citation records this snapshot. The page link may show a newer release later.	−USD 39.82 million Exact value Exact value: -39821082 USD 2002-01-01 – 2002-12-31: -39821082 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EYETECH PHARMACEUTICALS INC · 2002-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Operating Cash Flow: -39821082 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -39821082 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#20194 The citation records this snapshot. The page link may show a newer release later.	USD 582,330 Exact value Exact value: 582330 USD 2002-01-01 – 2002-12-31: 582330 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EYETECH PHARMACEUTICALS INC · 2002-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Capital Expenditure: 582330 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 582330 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#20232 The citation records this snapshot. The page link may show a newer release later.	−USD 40.4 million Calculation and evidence -39821082 − 582330 USD Exact free cash flow: -40403412 USD 2002-01-01 – 2002-12-31: -39821082 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 582330 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EYETECH PHARMACEUTICALS INC · 2002-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Free cash flow: -40403412 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -39821082 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#20194 Input fundies:CapitalExpenditure: 582330 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#20232 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 40.7 million Exact value Exact value: -40699245 USD 2003-01-01 – 2003-12-31: -40699245 USD Inspect Net Income Open source Share or cite Citation for Net Income · EYETECH PHARMACEUTICALS INC · 2003-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Net Income: -40699245 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -40699245 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#19895 The citation records this snapshot. The page link may show a newer release later.	USD 39.44 million Exact value Exact value: 39440745 USD 2003-01-01 – 2003-12-31: 39440745 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EYETECH PHARMACEUTICALS INC · 2003-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Operating Cash Flow: 39440745 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 39440745 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#20194 The citation records this snapshot. The page link may show a newer release later.	USD 3.78 million Exact value Exact value: 3778026 USD 2003-01-01 – 2003-12-31: 3778026 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EYETECH PHARMACEUTICALS INC · 2003-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Capital Expenditure: 3778026 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3778026 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#20232 The citation records this snapshot. The page link may show a newer release later.	USD 35.66 million Calculation and evidence 39440745 − 3778026 USD Exact free cash flow: 35662719 USD 2003-01-01 – 2003-12-31: 39440745 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 3778026 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EYETECH PHARMACEUTICALS INC · 2003-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Free cash flow: 35662719 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 39440745 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#20194 Input fundies:CapitalExpenditure: 3778026 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#20232 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 100.51 million Exact value Exact value: -100505807 USD 2004-01-01 – 2004-12-31: -100505807 USD Inspect Net Income Open source Share or cite Citation for Net Income · EYETECH PHARMACEUTICALS INC · 2004-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Net Income: -100505807 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -100505807 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#19895 The citation records this snapshot. The page link may show a newer release later.	−USD 66.51 million Exact value Exact value: -66514060 USD 2004-01-01 – 2004-12-31: -66514060 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · EYETECH PHARMACEUTICALS INC · 2004-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Operating Cash Flow: -66514060 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -66514060 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#20194 The citation records this snapshot. The page link may show a newer release later.	USD 12.53 million Exact value Exact value: 12532316 USD 2004-01-01 – 2004-12-31: 12532316 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · EYETECH PHARMACEUTICALS INC · 2004-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Capital Expenditure: 12532316 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12532316 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#20232 The citation records this snapshot. The page link may show a newer release later.	−USD 79.05 million Calculation and evidence -66514060 − 12532316 USD Exact free cash flow: -79046376 USD 2004-01-01 – 2004-12-31: -66514060 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 12532316 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · EYETECH PHARMACEUTICALS INC · 2004-12-31 EYETECH PHARMACEUTICALS INC (edgar:1115285) Free cash flow: -79046376 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T13:41:06Z Snapshot: 8f59a16ea4d911a5ef318c7dc052a942c0bc6bf0fe5be35937dbffb2a3bd04d7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1115285?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -66514060 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#20194 Input fundies:CapitalExpenditure: 12532316 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1115285/0000950123-05-003407.txt#20232 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

10 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-04. Source filing dates and reporting periods are shown separately.

Identifiers: 0001115285, 1115285, edgar:1115285

EYETECH PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Net income

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation